Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: Results of a cross-sectional epidemiological survey in Gran Canaria, Spain

Authors: Mauro Boronat, Pedro Saavedra, Nuria Pérez-Martín, María J López-Madrazo, Carlos Rodríguez-Pérez, Francisco J Nóvoa

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Recent data suggest that concentrations of lipoprotein(a) [Lp(a)] may be inversely associated with the risk of diabetes. This study analyzed the relationships between Lp(a) and both diabetes and insulin resistance in an adult cohort from the island of Gran Canaria, Spain.

Methods

Lp(a), homeostasis model assessment for insulin resistance (HOMA-IR) and conventional risk factors for diabetes were assessed in a sample of 1,030 adult individuals participating in a cross-sectional population-based epidemiological survey in the city of Telde. Diabetes was defined according to the WHO 1999 criteria, or as a previous diagnosis of diabetes. To identify patients at risk for diabetes, an Lp(a) cutoff level of 46 mg/dl was selected previously using classification and regression tree analysis. A multivariate logistic regression model with L2-regularization was used to assess the independent effect of Lp(a) on diabetes and its interactions with variables traditionally linked to the disease. Additionally, to investigate the effect of Lp(a) on insulin resistance, a parametric model was developed to describe the relationship between age and HOMA-IR values in subjects with levels of Lp(a) ≤46 or >46 mg/dl.

Results

Along with variables known to be associated with diabetes, including age, mean blood pressure, serum triglycerides, and an interaction term between age and low HDL cholesterol, the logistic model identified a significant inverse association for diabetes and the interaction term between age and Lp(a) levels >46 mg/dl. According to the proposed parametric model, HOMA-IR was significantly lower in subjects of all ages who had Lp(a) levels >46 mg/dl.

Conclusions

These results suggest that the age-related increase in the probability of having diabetes is significantly lower in subjects with Lp(a) levels >46 mg/dl. This could be explained in part by a lower insulin resistance in this subset of the population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M-R, Tokgözoglu L, Tybjærg-Hansen A, for the European Atherosclerosis Society Consensus Panel: Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010, 31: 2844-2853. 10.1093/eurheartj/ehq386.PubMedCentralCrossRefPubMed Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen M-R, Tokgözoglu L, Tybjærg-Hansen A, for the European Atherosclerosis Society Consensus Panel: Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010, 31: 2844-2853. 10.1093/eurheartj/ehq386.PubMedCentralCrossRefPubMed
2.
go back to reference Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90 % of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992, 90: 52-60. 10.1172/JCI115855.PubMedCentralCrossRefPubMed Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90 % of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992, 90: 52-60. 10.1172/JCI115855.PubMedCentralCrossRefPubMed
3.
go back to reference Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG: Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009, 301: 2331-2339. 10.1001/jama.2009.801.CrossRefPubMed Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG: Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009, 301: 2331-2339. 10.1001/jama.2009.801.CrossRefPubMed
4.
go back to reference Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS: Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol. 2011, 10: 46-57. 10.1186/1475-2840-10-46.PubMedCentralCrossRefPubMed Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS: Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol. 2011, 10: 46-57. 10.1186/1475-2840-10-46.PubMedCentralCrossRefPubMed
5.
go back to reference Herder C, Karakas M, Koenig W: Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther. 2011, 90: 52-66. 10.1038/clpt.2011.93.CrossRefPubMed Herder C, Karakas M, Koenig W: Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther. 2011, 90: 52-66. 10.1038/clpt.2011.93.CrossRefPubMed
6.
go back to reference Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH: Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011, 10: 103-110. 10.1186/1475-2840-10-103.PubMedCentralCrossRefPubMed Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH: Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011, 10: 103-110. 10.1186/1475-2840-10-103.PubMedCentralCrossRefPubMed
7.
go back to reference Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD: Plasma apolipoprotein (a) is increased in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1992, 35: 1055-1059. 10.1007/BF02221681.CrossRefPubMed Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD: Plasma apolipoprotein (a) is increased in Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1992, 35: 1055-1059. 10.1007/BF02221681.CrossRefPubMed
8.
go back to reference Habib SS, Aslam M, Shah SFA, Naveed AK: Lipoprotein (a) is associated with basal insulin levels in patients with type 2 diabetes mellitus. Arq Bras Cardiol. 2009, 93: 25-30.CrossRef Habib SS, Aslam M, Shah SFA, Naveed AK: Lipoprotein (a) is associated with basal insulin levels in patients with type 2 diabetes mellitus. Arq Bras Cardiol. 2009, 93: 25-30.CrossRef
9.
go back to reference Haffner SM, Morales PA, Stern MP, Gruber KK: Lp(a) concentrations in NIDDM. Diabetes. 1992, 41: 1267-1272. 10.2337/diabetes.41.10.1267.CrossRefPubMed Haffner SM, Morales PA, Stern MP, Gruber KK: Lp(a) concentrations in NIDDM. Diabetes. 1992, 41: 1267-1272. 10.2337/diabetes.41.10.1267.CrossRefPubMed
10.
go back to reference Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM: Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes. 1994, 43: 942-946. 10.2337/diabetes.43.7.942.CrossRefPubMed Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM: Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes. 1994, 43: 942-946. 10.2337/diabetes.43.7.942.CrossRefPubMed
11.
go back to reference Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM: Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010, 56: 1252-1260. 10.1373/clinchem.2010.146779.PubMedCentralCrossRefPubMed Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM: Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010, 56: 1252-1260. 10.1373/clinchem.2010.146779.PubMedCentralCrossRefPubMed
12.
go back to reference Boronat M, Varillas VF, Saavedra P, Suárez V, Bosch E, Carrillo A, Nóvoa FJ: Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med. 2006, 23: 148-155.CrossRefPubMed Boronat M, Varillas VF, Saavedra P, Suárez V, Bosch E, Carrillo A, Nóvoa FJ: Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med. 2006, 23: 148-155.CrossRefPubMed
13.
go back to reference World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of Diabetes Mellitus. 1999, World Health Organization, Geneva, 1-59. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of Diabetes Mellitus. 1999, World Health Organization, Geneva, 1-59.
14.
go back to reference Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
15.
go back to reference Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and regression trees. 1984, Wadsworth International, Belmont, CA Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and regression trees. 1984, Wadsworth International, Belmont, CA
16.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
17.
go back to reference Park MY, Hastie T: Penalized logistic regression for detecting gene interactions. Biostatistics. 2008, 9: 30-50.CrossRefPubMed Park MY, Hastie T: Penalized logistic regression for detecting gene interactions. Biostatistics. 2008, 9: 30-50.CrossRefPubMed
18.
go back to reference Qi Q, Workalemahu T, Zhang C, Hu FB, Qi L: Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J. 2012, 33: 325-334. 10.1093/eurheartj/ehr350.PubMedCentralCrossRefPubMed Qi Q, Workalemahu T, Zhang C, Hu FB, Qi L: Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J. 2012, 33: 325-334. 10.1093/eurheartj/ehr350.PubMedCentralCrossRefPubMed
19.
go back to reference Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, Ishikawa S, Kario K, Nakamura Y, Igarashi M: Serum insulin and lipoprotein(a) concentrations. Diabetes Care. 1997, 20: 1242-1247. 10.2337/diacare.20.8.1242.CrossRefPubMed Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, Ishikawa S, Kario K, Nakamura Y, Igarashi M: Serum insulin and lipoprotein(a) concentrations. Diabetes Care. 1997, 20: 1242-1247. 10.2337/diacare.20.8.1242.CrossRefPubMed
20.
go back to reference Dahlën G, Berg K: Confirmation of an influence of the inherited Lp(a) variation on serum insulin and glucose levels. Clin Genet. 1979, 16: 418-427.CrossRefPubMed Dahlën G, Berg K: Confirmation of an influence of the inherited Lp(a) variation on serum insulin and glucose levels. Clin Genet. 1979, 16: 418-427.CrossRefPubMed
21.
go back to reference Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G, Laakso M: Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care. 1995, 18: 193-199. 10.2337/diacare.18.2.193.CrossRefPubMed Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G, Laakso M: Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care. 1995, 18: 193-199. 10.2337/diacare.18.2.193.CrossRefPubMed
22.
go back to reference Rainwater DL, Haffner SM: Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol. 1998, 18: 1335-1341. 10.1161/01.ATV.18.8.1335.CrossRefPubMed Rainwater DL, Haffner SM: Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol. 1998, 18: 1335-1341. 10.1161/01.ATV.18.8.1335.CrossRefPubMed
23.
go back to reference Sharma S, Merchant J, Fleming SE: Lp(a)-cholesterol is associated with HDLcholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc Diabetol. 2012, 11: 10-17. 10.1186/1475-2840-11-10.PubMedCentralCrossRefPubMed Sharma S, Merchant J, Fleming SE: Lp(a)-cholesterol is associated with HDLcholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc Diabetol. 2012, 11: 10-17. 10.1186/1475-2840-11-10.PubMedCentralCrossRefPubMed
Metadata
Title
High levels of lipoprotein(a) are associated with a lower prevalence of diabetes with advancing age: Results of a cross-sectional epidemiological survey in Gran Canaria, Spain
Authors
Mauro Boronat
Pedro Saavedra
Nuria Pérez-Martín
María J López-Madrazo
Carlos Rodríguez-Pérez
Francisco J Nóvoa
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-81

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue